326 related articles for article (PubMed ID: 16854754)
1. The efficacy of combined PUVA and low-dose azathioprine for early and enhanced repigmentation in vitiligo patients.
Radmanesh M; Saedi K
J Dermatolog Treat; 2006; 17(3):151-3. PubMed ID: 16854754
[TBL] [Abstract][Full Text] [Related]
2. Psoralen and ultraviolet A and narrow-band ultraviolet B in inducing stability in vitiligo, assessed by vitiligo disease activity score: an open prospective comparative study.
Bhatnagar A; Kanwar AJ; Parsad D; De D
J Eur Acad Dermatol Venereol; 2007 Nov; 21(10):1381-5. PubMed ID: 17958845
[TBL] [Abstract][Full Text] [Related]
3. Randomized double-blind trial of treatment of vitiligo: efficacy of psoralen-UV-A therapy vs Narrowband-UV-B therapy.
Yones SS; Palmer RA; Garibaldinos TM; Hawk JL
Arch Dermatol; 2007 May; 143(5):578-84. PubMed ID: 17519217
[TBL] [Abstract][Full Text] [Related]
4. Psoralen-ultraviolet A vs. narrow-band ultraviolet B phototherapy for the treatment of vitiligo.
Parsad D; Kanwar AJ; Kumar B
J Eur Acad Dermatol Venereol; 2006 Feb; 20(2):175-7. PubMed ID: 16441626
[TBL] [Abstract][Full Text] [Related]
5. Experience with calcipotriol as adjunctive treatment for vitiligo in patients who do not respond to PUVA alone: a preliminary study.
Yalçin B; Sahin S; Bükülmez G; Karaduman A; Atakan N; Akan T; Kölemen F
J Am Acad Dermatol; 2001 Apr; 44(4):634-7. PubMed ID: 11260538
[TBL] [Abstract][Full Text] [Related]
6. Treatment of vitiligo with UV-B radiation vs topical psoralen plus UV-A.
Westerhof W; Nieuweboer-Krobotova L
Arch Dermatol; 1997 Dec; 133(12):1525-8. PubMed ID: 9420536
[TBL] [Abstract][Full Text] [Related]
7. Topical tacrolimus and the 308-nm excimer laser: a synergistic combination for the treatment of vitiligo.
Passeron T; Ostovari N; Zakaria W; Fontas E; Larrouy JC; Lacour JP; Ortonne JP
Arch Dermatol; 2004 Sep; 140(9):1065-9. PubMed ID: 15381545
[TBL] [Abstract][Full Text] [Related]
8. Comparison of systemic PUVA and NB-UVB in the treatment of vitiligo: an open prospective study.
Bhatnagar A; Kanwar AJ; Parsad D; De D
J Eur Acad Dermatol Venereol; 2007 May; 21(5):638-42. PubMed ID: 17447977
[TBL] [Abstract][Full Text] [Related]
9. High-dose prednisolone and psoralen ultraviolet A combination therapy in 36 patients with vitiligo.
Lee Y; Seo YJ; Lee JH; Park JK
Clin Exp Dermatol; 2007 Sep; 32(5):499-501. PubMed ID: 17608760
[TBL] [Abstract][Full Text] [Related]
10. Systemic PUVA vs. narrowband UVB in the treatment of vitiligo: a randomized controlled study.
Sapam R; Agrawal S; Dhali TK
Int J Dermatol; 2012 Sep; 51(9):1107-15. PubMed ID: 22909369
[TBL] [Abstract][Full Text] [Related]
11. Effect of topical calcipotriol, betamethasone dipropionate and their combination in the treatment of localized vitiligo.
Kumaran MS; Kaur I; Kumar B
J Eur Acad Dermatol Venereol; 2006 Mar; 20(3):269-73. PubMed ID: 16503885
[TBL] [Abstract][Full Text] [Related]
12. Calcipotriol and PUVA as treatment for vitiligo.
Cherif F; Azaiz MI; Ben Hamida A; Ben O; Dhari A
Dermatol Online J; 2003 Dec; 9(5):4. PubMed ID: 14996377
[TBL] [Abstract][Full Text] [Related]
13. [Long-term effects of PUVA therapy on Israeli patients with vitiligo].
Vussuki E; Ziv M; Rosenman D; David M
Harefuah; 2006 Jul; 145(7):483-5, 552, 551. PubMed ID: 16900734
[TBL] [Abstract][Full Text] [Related]
14. Oral psoralen with UV-A therapy releases circulating growth factor(s) that stimulates cell proliferation.
Abdel-Naser MB; Hann SK; Bystryn JC
Arch Dermatol; 1997 Dec; 133(12):1530-3. PubMed ID: 9420537
[TBL] [Abstract][Full Text] [Related]
15. Narrow-band ultraviolet B as monotherapy and in combination with topical calcipotriol in the treatment of vitiligo.
Arca E; Taştan HB; Erbil AH; Sezer E; Koç E; Kurumlu Z
J Dermatol; 2006 May; 33(5):338-43. PubMed ID: 16700666
[TBL] [Abstract][Full Text] [Related]
16. Randomized study of interferon beta-1a, low-dose azathioprine, and low-dose corticosteroids in multiple sclerosis.
Havrdova E; Zivadinov R; Krasensky J; Dwyer MG; Novakova I; Dolezal O; Ticha V; Dusek L; Houzvickova E; Cox JL; Bergsland N; Hussein S; Svobodnik A; Seidl Z; Vaneckova M; Horakova D
Mult Scler; 2009 Aug; 15(8):965-76. PubMed ID: 19465443
[TBL] [Abstract][Full Text] [Related]
17. Topical tacalcitol and 308-nm monochromatic excimer light: a synergistic combination for the treatment of vitiligo.
Lu-yan T; Wen-wen F; Lei-hong X; Yi J; Zhi-zhong Z
Photodermatol Photoimmunol Photomed; 2006 Dec; 22(6):310-4. PubMed ID: 17100739
[TBL] [Abstract][Full Text] [Related]
18. Treatment of vitiligo with broadband ultraviolet B and vitamins.
Don P; Iuga A; Dacko A; Hardick K
Int J Dermatol; 2006 Jan; 45(1):63-5. PubMed ID: 16426381
[TBL] [Abstract][Full Text] [Related]
19. Targeted and combination treatments for vitiligo. Comparative evaluation of different current modalities in 458 subjects.
Lotti T; Buggiani G; Troiano M; Assad GB; Delescluse J; De Giorgi V; Hercogova J
Dermatol Ther; 2008 Jul; 21 Suppl 1():S20-6. PubMed ID: 18727812
[TBL] [Abstract][Full Text] [Related]
20. Treatment of vitiligo vulgaris with narrow-band UVB and oral Polypodium leucotomos extract: a randomized double-blind placebo-controlled study.
Middelkamp-Hup MA; Bos JD; Rius-Diaz F; Gonzalez S; Westerhof W
J Eur Acad Dermatol Venereol; 2007 Aug; 21(7):942-50. PubMed ID: 17659004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
